Medicare Will Pay Your AI Agent Now
Medicare's ACCESS model is the first federal mechanism to reimburse AI agents that monitor patients between visits, coordinate referrals, and manage care. For founders eyeing healthcare, this is the revenue model youwere
The CMS Rule Most Builders Missed
The Centers for Medicare & Medicaid Services slipped a payment model called ACCESS into the federal register. It does something no previous healthcare regulation has done. It creates billing codes and reimbursement pathways for AI agents that work between doctor visits. For decades, healthcare software made money by selling dashboards to hospitals or charging per-seat SaaS fees to clinics. ACCESS breaks from that model entirely. It treats persistent, autonomous care coordination as a billable service.
Most of the tech press ignored this story because it wore a suit and spoke in acronyms. But the builders who pay attention are the ones who will own the next wave of health tech. ACCESS specifically reimburses agents that monitor patients remotely, check in by phone or text, coordinate housing referrals, and verify medication adherence. These are not diagnostic tools that sit inside an EHR. They are outward-facing, ongoing interactions with real patients. That is a radically different product category.
Why This Changes the Economics of Health AI
Healthcare AI startups have historically died on the same hill. They built beautiful models that predicted readmissions or flagged sepsis risk, then discovered hospitals had no budget line for AI predictions. ACCESS reimburses ongoing coordination, not one-off insights. If your agent keeps a diabetic patient out of the emergency room by nudging them to refill insulin, Medicare can pay for that nudge. The unit economics finally make sense.
This opens the door for small teams to compete with incumbent care-management giants. You do not need a fifty-person sales force to crack hospital procurement. You need an agent that reliably performs a reimbursable task and passes the compliance basics. The check size from CMS is modest per patient per month, but at scale it compounds fast. A single agent handling medication adherence for ten thousand patients generates real recurring revenue.
What You Actually Need to Ship
The reimbursement pathway exists now. The technology does not build itself. An ACCESS-eligible agent needs a backend that handles scheduled outreach, tracks patient responses, escalates to humans when thresholds break, and logs everything for audit. It needs to run continuously, react in real time, and survive HIPAA scrutiny. That used to require a team of DevOps engineers, a database specialist, and a compliance consultant.
Today a solo founder can assemble this stack in hours. Convex handles the reactive backend and durable workflows. Expo and Vite ship the patient-facing interfaces. NativeWind covers web and mobile from one codebase. The agent logic, the scheduling, the escalation rules, the audit trail, all of it can be prototyped conversationally and pushed to GitHub in an afternoon. That infrastructure gap just collapsed.
You still have policy work ahead. ACCESS is new, and local Medicare Administrative Contractors will interpret it differently. You will need legal review. You will need to prove outcomes. But the hardest barrier, the one that killed thousands of health tech pitches before they started, is gone. There is now a federal mechanism that pays for AI agents doing real work in the world.
The best time to build in healthcare was ten years ago. The second best time is the month before your competitors realize CMS just handed them a business model. Most of the tech world has no idea this happened. That is your window.